Articles for tag: Director, Estate, Grants, Halted, insolvency, Looming, NCLAT, Project, Propose, Real, Settlement, Supertechs, Suspended, Threatens, Weeks

Market News

NCLAT grants Supertech’s suspended director two weeks to propose a settlement, while looming insolvency threatens the halted real estate project.

NCLAT grants Supertech’s suspended director two weeks to propose a settlement, while looming insolvency threatens the halted real estate project.

The National Company Law Appellate Tribunal (NCLAT) has given Ram Kishore Arora, suspended director of Supertech Township Projects, an additional two weeks to share a settlement proposal with lenders and homebuyers. This decision comes as Arora aims to resolve ongoing insolvency proceedings connected to the company’s real estate project, which has faced delays. NCLAT suggested ...

Market News

Supreme Court to hear Byju’s insolvency case amid creditor disputes and a critical Rs 158.9 crore settlement with BCCI.

Supreme Court to hear Byju’s insolvency case amid creditor disputes and a critical Rs 158.9 crore settlement with BCCI.

The Supreme Court is set to hear an appeal on September 17 from Glas Trust Company LLC, a US-based creditor, regarding the ed-tech firm BYJU’s. This follows a previous National Company Law Appellate Tribunal (NCLAT) decision that paused insolvency proceedings against BYJU’s and approved a Rs 158.9 crore settlement with the Board of Control for ...

Market News

Supreme Court to hear Byju’s insolvency case amid creditor disputes and a critical Rs 158.9 crore settlement with BCCI.

Supreme Court delays insolvency proceedings against Byju’s amid disputes over a ₹158.9 crore settlement with BCCI, fueling financial drama.

The Supreme Court has agreed to hear an appeal from Glas Trust Company LLC, a US creditor, regarding a recent NCLAT judgment that paused insolvency proceedings against Byju’s, the prominent ed-tech firm. This decision comes after NCLAT approved a Rs 158.9 crore settlement with the BCCI over outstanding sponsorship payments. Byju’s lawyers argue the petition ...

Market News

Glenmark Pharmaceuticals agrees to a  million settlement over drug pricing misconduct, reflecting ongoing challenges in the pharmaceutical industry.

Glenmark Pharmaceuticals agrees to a $25 million settlement over drug pricing misconduct, reflecting ongoing challenges in the pharmaceutical industry.

Glenmark Pharmaceuticals has reached a settlement with the US Department of Justice, agreeing to pay $25 million due to a case involving the pricing of a generic drug. This payment will be made in six installments over five years, accruing interest at a rate of 4.25 percent from May 2024. The settlement, announced in a ...

DeFi Explained: Simple Guide Green Crypto and Sustainability China’s Stock Market Rally and Outlook The Future of NFTs The Rise of AI in Crypto